Anacetrapib: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk (Chemical structure drawing inserted) |
imported>David E. Volk (Chem info box added) |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
{{Image | |||
{{Chem infobox | |||
|align=right | |||
|image=[[Image:Anacetrapib.png|center|thumb|300px]] | |||
|width=300px | |||
|molname=anacetrapib | |||
|synonyms= | |||
|molformula= C<sub>30</sub>H<sub>25</sub>F<sub>10</sub>NO<sub>3 | |||
|molmass= 637.51 | |||
|uses=antifungal | |||
|properties= | |||
|hazards= | |||
|iupac= see below | |||
|casnumber= 875446-37-0} | |||
} | |||
In [[health care]], '''anacetrapib''' (anacet'rapib) is an oxazolidinone [[medication]] that is a cholesteryl ester transfer protein inhibitor that raises [[HDL cholesterol]] and reduces [[LDL cholesterol]].<ref>{{MeSH}}</ref> | In [[health care]], '''anacetrapib''' (anacet'rapib) is an oxazolidinone [[medication]] that is a cholesteryl ester transfer protein inhibitor that raises [[HDL cholesterol]] and reduces [[LDL cholesterol]].<ref>{{MeSH}}</ref> | ||
Revision as of 09:04, 26 November 2010
{{Chem infobox |align=right
|image=
|width=300px |molname=anacetrapib |synonyms= |molformula= C30H25F10NO3 |molmass= 637.51 |uses=antifungal |properties= |hazards= |iupac= see below |casnumber= 875446-37-0} }
In health care, anacetrapib (anacet'rapib) is an oxazolidinone medication that is a cholesteryl ester transfer protein inhibitor that raises HDL cholesterol and reduces LDL cholesterol.[1]
Anacetrapib is related to torcetrapib.[2]
References
- ↑ Anonymous (2024), Anacetrapib (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM et al. (2010). "Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease.". N Engl J Med. DOI:10.1056/NEJMoa1009744. PMID 21082868. Research Blogging.